{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:24:37Z","timestamp":1762143877040},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1006\/taap.2000.9041","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:01:25Z","timestamp":1032386485000},"page":"8-16","source":"Crossref","is-referenced-by-count":58,"title":["Proarrhythmic Effects of Fluoroquinolone Antibacterial Agents: In Vivo Effects as Physiologic Substrate for Torsades"],"prefix":"10.1006","volume":"169","author":[{"given":"Katsuyoshi","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshioki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/taap.2000.9041_RF1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1472-8206.1998.tb00926.x","article-title":"Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers","volume":"12","author":"Adamantidis","year":"1998","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF2","unstructured":"Baim, D. S., and Grossman, W.1995. Cardiac catheterization, angiography, and intervention, 5th ed., In Percutaneous Approach Including Trans-Septal and Apical Puncture (Baim, D. S., Ed.), pp. 57\u201381. Williams and Wilkins, Baltimore, MD."},{"key":"10.1006\/taap.2000.9041_RF3","first-page":"353","article-title":"An analysis of the time-relations of electrocardiogram","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1006\/taap.2000.9041_RF4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-2918(00)88266-1","article-title":"Expanded activity and utility of the new fluoroquinolones: A review","volume":"21","author":"Blondeau","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1006\/taap.2000.9041_RF5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0378-4347(92)80393-5","article-title":"Determination of sparfloxacin in serum and urine by high-performance liquid chromatography","volume":"579","author":"Borner","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1006\/taap.2000.9041_RF6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00005344-199908000-00009","article-title":"Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide","volume":"34","author":"Chen","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00003495-199447040-00008","article-title":"Levofloxacin; A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1006\/taap.2000.9041_RF8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2125.1996.03394.x","article-title":"Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers","volume":"41","author":"Demolis","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF01695673","article-title":"Torsades de pointe probably related to sparfloxacin","volume":"15","author":"Dupont","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1006\/taap.2000.9041_RF10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1540-8167.1994.tb01192.x","article-title":"Bridging the gap between basic and clinical electrophysiology: What can be learned from monophasic action potential recordings?","volume":"5","author":"Franz","year":"1994","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1006\/taap.2000.9041_RF11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.77.5.1177","article-title":"Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ","volume":"77","author":"Franz","year":"1988","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2165\/00003495-199753040-00010","article-title":"Sparfloxacin: A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections","volume":"53","author":"Goa","year":"1997","journal-title":"Drugs"},{"key":"10.1006\/taap.2000.9041_RF13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF00120829","article-title":"Effects of antiarrhythmic drugs on canine ventricular arrhythmia model: Which electrophysiological characteristics of drugs are related to their effectiveness?","volume":"5","author":"Hashimoto","year":"1991","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1006\/taap.2000.9041_RF14","first-page":"195","article-title":"Four-week oral subacute toxicity study of sparfloxacin in beagle dogs","volume":"39","author":"Iida","year":"1991","journal-title":"Chemotherapy (Tokyo)"},{"key":"10.1006\/taap.2000.9041_RF15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/37.suppl_A.161","article-title":"Overview of electrocardiographic and cardiovascular safety data for sparfloxacin","volume":"37","author":"Jaillon","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1006\/taap.2000.9041_RF16","unstructured":"Jalife, J, Delmer, M, Davidenko, J. M, Anumonwo, J. M. B. 1999, Basic Cardiac Electrophysiology for the Clinician, Futura Publishing, New York."},{"key":"10.1006\/taap.2000.9041_RF17","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.CIR.97.25.2567","article-title":"Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: Antiarrhythmic and proarrhythmic effects","volume":"97","author":"Kirchhof","year":"1998","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1345\/aph.17178","article-title":"Levofloxacin and sparfloxacin: New quinolone antibiotics","volume":"32","author":"Martin","year":"1998","journal-title":"Ann. Pharmacother."},{"key":"10.1006\/taap.2000.9041_RF19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/37.suppl_A.27","article-title":"Pharmacokinetics of sparfloxacin in healthy volunteers and patients: A review","volume":"37","author":"Montay","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1006\/taap.2000.9041_RF20","first-page":"157","article-title":"General pharmacology of sparfloxacin, a new quinolone antibacterial agent: 2. Effects on the respiratory, cardiovascular and autonomic nervous system functions","volume":"41","author":"Nakatsuji","year":"1991","journal-title":"Pharmacometrics"},{"key":"10.1006\/taap.2000.9041_RF21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0378-4347(91)80037-D","article-title":"High performance liquid chromatographic determination of (s)-(\u2212)-ofloxacin and its metabolites in serum and urine using a solid-phase clean-up","volume":"563","author":"Okazaki","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1006\/taap.2000.9041_RF22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.CIR.94.2.217","article-title":"Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs","volume":"94","author":"Satoh","year":"1996","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1254\/jjp.81.79","article-title":"Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters","volume":"81","author":"Satoh","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/taap.1996.8061","article-title":"Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring","volume":"143","author":"Sugiyama","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/taap.1998.8494","article-title":"Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring","volume":"152","author":"Sugiyama","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/taap.1996.0148","article-title":"Effects of antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording","volume":"139","author":"Sugiyama","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2000.9041_RF27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01744586","article-title":"Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model","volume":"13","author":"Usui","year":"1998","journal-title":"Heart Vessels"},{"key":"10.1006\/taap.2000.9041_RF28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.98.11.1136","article-title":"Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes","volume":"98","author":"Volders","year":"1998","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.CIR.98.11.1125","article-title":"Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling","volume":"98","author":"Vos","year":"1998","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.91.3.864","article-title":"Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block","volume":"91","author":"Vos","year":"1995","journal-title":"Circulation"},{"key":"10.1006\/taap.2000.9041_RF31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0160-5402(91)90051-6","article-title":"Methods and limitations of an experimental model of long QT syndrome","volume":"26","author":"Weissenburger","year":"1991","journal-title":"J. Pharmacol. Meth."},{"key":"10.1006\/taap.2000.9041_RF32","first-page":"871","article-title":"Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: Comparison between quinidine, lidocaine, flecainide, propranolol and sotalol","volume":"259","author":"Weissenburger","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X00990410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X00990410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T23:50:20Z","timestamp":1557359420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X00990410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0041008X00990410"],"URL":"https:\/\/doi.org\/10.1006\/taap.2000.9041","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}